Recently, Mr.Yunlong Song, Member of the Swiss Federal Ministry of Culture, Ms.Li Ying, Chairperson of the China-Switzerland 75th Anniversary Summit Forum, Mr.Hans Strub, Advisor of the Forum, and Mr.Chen Sihan, Sponsor of the Forum,visited Shenzhen Cell Valley to conduct in-depth exchanges and collaborative discussions.Professor Shi Yuanyuan, Chairman of our company, Mr.Fu Yuchen, Assistant to the Chairman, and Ms.Sun Rui,Director of the Marketing Department, extended a warm welcome. Both sides engaged in discussions on topics such as technological innovation in cell therapy and international industrial cooperation.

Accompanied by Chairman's Assistant Fu Yuchen, the visiting guests first toured the Shenzhen Cell Valley Smart Exhibition Hall, where they gained a systematic understanding of the company's full industrial chain layout in the field of cell and gene therapy. As the only CRO/CDMO service provider in China with clinical-grade GMP industrial production capacity for retroviral vectors (RVV), Shenzhen Cell Valley has established a production line exceeding 10,000 square meters that meets international GMP standards for viral vectors and cell products. The single-batch production capacity of RVV exceeds 1,000 human units, and the CAR-T cell transduction efficiency reaches over 70%.

At the symposium, Professor Shi Yuanyuan, Chairman of the Board, extended a warm welcome to all distinguished guests. He emphasized that Shenzhen Cell Valley has always adhered to the mission of 'Cells benefiting all beings, genes creating the future.' The company has not only established the Cell Therapy Translational Research Institute in collaboration with Shenzhen Hospital of Southern Medical University but also engaged in deep cooperation with institutions such as the National Engineering Research Center for Key Common Technologies in the Cell Industry, building a comprehensive service platform covering the entire lifecycle from vector design to clinical application. Looking ahead, Shenzhen Cell Valley will leverage the opportunity of the 75th Anniversary Summit Cooperation Forum of China-Switzerland Diplomatic Relations to foster exchanges and collaborations with the Swiss medical and pharmaceutical sectors.

Mr.Hans Strub stated that as a strategic high ground in the field of biomedicine, cell therapy urgently requires cross-border resource integration and technological iteration. Mr.Yunlong Song, Member of the Federal Ministry of Culture of Switzerland, also expressed his willingness to leverage this visit as an opportunity to build a bridge for Sino-Swiss collaboration in the cell therapy industry, facilitating the global dissemination of innovative achievements in life sciences between the two countries.

Professor Shi Yuanyuan stated that Shenzhen Cell Valley is committed to promoting international scientific and cultural exchanges and cooperation, hoping to further enhance the internationalization level of cell therapy technology through collaboration with the Swiss medical community. This exchange is an important action for Shenzhen Cell Valley to implement its internationalization strategy. In the future, the company will continue to adopt an open and innovative cooperative attitude, working with global partners to explore new frontiers in cell technology, contributing China's wisdom and Shenzhen's strength to the cause of human health.